HomeLIMN • NASDAQ
add
Liminatus Pharma Inc
Previous close
$1.21
Day range
$1.23 - $1.30
Year range
$1.12 - $33.66
Market cap
33.83M USD
Avg Volume
1.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.12M | 22.99% |
Net income | 113.29K | 111.79% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.12M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.34M | 294.52% |
Total assets | 1.91M | -46.01% |
Total liabilities | 10.72M | -45.12% |
Total equity | -8.81M | — |
Shares outstanding | 27.06M | — |
Price to book | -3.56 | — |
Return on assets | — | — |
Return on capital | 75.90% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 113.29K | 111.79% |
Cash from operations | -8.98M | -712.82% |
Cash from investing | -775.00K | 48.33% |
Cash from financing | 11.03M | 400.58% |
Net change in cash | 1.28M | 420.25% |
Free cash flow | — | — |
About
Founded
2020
Headquarters
